삼성서울병원

Ko En

Nuclear Medicine Lee, Kyung Han M.D

Expertise
Nuclear Oncology, Nuclear Neurology
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Seoul National University Hospital
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Professional Memberships

Member, Korean Medical Association
Member, Korean Association of Internal Medicine
Member and Scientific Committee, Korean Society of Nuclear Medicine
Member, Korean Society of Biochemistry and Molecular Biology
Member, Society of Nuclear Medicine
Member, European Association of Nuclear Medicine
Board of Trustee, Korean Society of Nuclear Medicine
Board of Trustee, Korean Society of Molecular Imaging

Editorial Board, Open Journal of Medical Imaging
Editorial Board, Open Journal of Nuclear Medicine
Editorial Board, Journal of Korean Medical Science
Editorial Board, Nuclear Medicine and Molecular Imaging

Selected Publications

  • SCI REP-UK 2021 10.1038/s41598-021-88815-2 Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation Park1, YJ; Hyun, SH; Moon, SH; Lee, KH; Min, BH; Lee, JH; Kim, WS; Kim, SJ; Choi, JY
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85332-0 Metabolic activity of extranodal NK/T cell lymphoma on F-18-FDG PET/CT according to immune subtyping Lim1, CH; Yoon, SE; Kim, SJ; Cho, J; Ko, YH; Lee, KH; Kim, WS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-83496-3 Zr-89 anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells Park1, JW; Jung, KH; Lee, JH; Moon, SH; Cho, YS; Lee, KH
    View PubMed
  • CANCERS 2021 10.3390/cancers13040712 Prognostic Significance of Metabolic Parameters by F-18-FDG PET/CT in Thymic Epithelial Tumors Lee1, J; Cho, YS; Kim, J; Shim, YM; Lee, KH; Choi, JY
    View PubMed
  • ONCOL LETT 2020 10.3892/ol.2020.12237 Genipin enhances the antitumor effect of elesclomol in A549 lung cancer cells by blocking uncoupling protein-2 and stimulating reactive oxygen species production Lee1, JH; Cho, YS; Jung, KH; Park, JW; Lee, KH
    View PubMed